The #
ShortCUT# trial sparked a lot of conversation, but not a change in perspective for Dr. William Dixon. In this new
@CardioBusiness article, the Blue Collar I.C. podcast host explains why he remains confident in a #
ShockwaveIVL-first# approach and continues to view it as the “gold standard” for calcium modification.
🔗
Dr. William C. Dixon is a paid consultant of Johnson & Johnson.
US Rx only. Safety Info:
Product availability may vary by country.